[Infections in children with malignant disease (author's transl)].
Infections of children with malignant disease, especially of the lympho-reticular system, are characterized by their severity, with a high mortality, as a consequence of defective immunocompetence. According to the immunosurveillance theory, temporary immune defects could have even facilitated the malignant growth. The neoplastic disease itself contributes to the immunodeficiency by multiple mechanisms. The powerful cytostatic-cytocidal drugs reduce the immune response also, especially in the phases of bone marrow depression. Granulocytopenia shows the most significant correlation with the incidence of serious infections. The different forms of hospital infections have been reviewed and classified as 1. bacterial, fungal and, rarely, (but most dangerous) protozoal infections, 2. endogenous infections with the patient's own anaerobic intestinal flora and 3. viral infections. The perspectives of up-to-date chemotherapy and management of the immunodeficiency e.g. with leucocyte transfusions, and attempts to prevent infection are discussed.
D000666:Amphotericin B / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001424:Bacterial Infections / Q000517:prevention & control; D001803:Blood Transfusion; D002648:Child; D003141:Communicable Diseases / Q000150:complications*; D003428:Cross Infection / Q000150:complications; D006801:Humans; D007157:Immunologic Surveillance; D007165:Immunosuppression Therapy; D007962:Leukocytes; D007970:Leukopenia / Q000150:complications; D008825:Miconazole / Q000627:therapeutic use; D009175:Mycoplasma Infections / Q000188:drug therapy; D009181:Mycoses / Q000188:drug therapy; D009369:Neoplasms / Q000150:complications*; D009748:Nutrition Disorders / Q000150:complications; D009761:Nystatin / Q000627:therapeutic use; D010356:Patient Isolation; D011528:Protozoan Infections / Q000517:prevention & control; D013754:Tetracyclines / Q000627:therapeutic use; D014777:Virus Diseases / Q000517:prevention & control
D000970:Antineoplastic Agents; D013754:Tetracyclines; D009761:Nystatin; D008825:Miconazole; D000666:Amphotericin B
Fortschritte der Medizin in Einzeldarstellungen, LVII.